Status:
COMPLETED
An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.
Lead Sponsor:
Novartis
Conditions:
Liver Transplantation
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The objectives of the study are:To compare the renal function of a quadruple immunosuppressive regimen (including basiliximab in combination with an optimized cyclosporine dose during the first weeks ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- First cadaveric liver transplant
- ABO identical or compatible graft
- Exclusion Criteria
- Multiple organ transplant
- renal impairment defined as glomerular filtration rate (GFR) \< 30 ml/min
- Fulminant liver failure
- Other protocol-defined exclusion criteria may apply.
Exclusion
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00343226
Start Date
May 1 2002
Last Update
August 25 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.